Ultragenyx Pharmaceutical, Inc. (RARE)
23.61
-0.10
(-0.42%)
USD |
NASDAQ |
May 22, 09:55
Ultragenyx Pharmaceutical Market Cap : 2.325B for May 22, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Catalyst Pharmaceuticals, Inc. | 3.829B |
| BioMarin Pharmaceutical, Inc. | 10.61B |
| Regeneron Pharmaceuticals, Inc. | 67.03B |
| Xencor, Inc. | 853.00M |
| REGENXBIO, Inc. | 342.24M |
Market Cap Related Metrics
| PS Ratio | 3.516 |
| PEG Ratio | -1.011 |
| Price | 23.61 |
| Earnings Yield | -25.86% |
| PEGY Ratio | -1.011 |